Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

for
Type 1 Diabetes Mellitus
Location: Seattle WA, Aurora CO, Pittsburgh PA, New York NY,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 4 - 34

Code: NCT07216391

Phase 2, Recruiting
Active & Responsive

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

for
Type 1 Diabetes Mellitus
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 8 - 45

Code: NCT07142252

Phase 2, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

for
Major Depressive Disorder (MDD)
Location: Bellevue WA, Walnut Creek CA, San Jose CA, Las Vegas NV,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06830044

Phase 3, Recruiting
Active & Responsive

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

for
Capsular Contracture Associated With Breast Implant,
Location: Seattle WA, Vancouver WA, Reno NV, Draper UT,
Sponsor: C. R. Bard

Sex: Female

Age: 22 - 70

Code: NCT05945329

Recruiting
Active & Responsive

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Seattle WA, Redwood City CA, Orange CA, Kansas City MO,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois

Sex: All

Age: 0 - 70+

Code: NCT05500807

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

for
Arthritis, Rheumatoid
Location: Seattle WA, Bothell WA, Spokane WA, Covina CA,
Sponsor: Crescendo Bioscience

Sex: All

Age: 18 - 70+

Code: NCT02832297

Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: Bellevue WA, Ogden UT, Lancaster CA, Los Angeles CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

Study of DONQ52 in Active Celiac Disease

for
Celiac Disease
Location: Bellevue WA, Reno NV, Folsom CA, Ogden UT,
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18 - 70+

Code: NCT07239336

Phase 2, Recruiting
Active & Responsive

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Bellevue WA, Seattle WA, Kirkland WA, Post Falls ID,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting
Active & Responsive

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for
Healthy
Location: Seattle WA, Garden City ID, Missoula MT, Boise ID,
Sponsor: Pfizer

Sex: All

Age: 0 - 49

Code: NCT07160244

Phase 3, Recruiting
Active & Responsive

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Bellevue WA, Spokane WA, San Leandro CA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 18+

Code: NCT07290036

Phase 1, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Bellevue WA, Salem OR, Walnut Creek CA, West Jordan UT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
Location: Bellevue WA, Portland OR, Reno NV, Layton UT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Phase 4, Recruiting
Active & Responsive

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Seattle WA, Vancouver, Calgary, Sandy City UT,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase 2, Recruiting
Active & Responsive

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Zenith Epigenetics

Sex: Male

Age: 18+

Code: NCT04986423

Phase 2, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: Seattle WA, Denver CO, Fargo ND, Dallas TX, Chicago IL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

for
Solid Tumor, Adult, Colorectal Cancer, Non-Small Cell Lung,
Location: Seattle WA, Los Angeles CA, La Jolla CA, Gilbert AZ,
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT06682793

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Seattle WA, Boise ID, Reno NV, Edmonton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase 3, Recruiting
Active & Responsive

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

for
Ductal Carcinoma in Situ
Location: Seattle WA, Walnut Creek CA, Berkeley CA,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: Female

Age: 18+

Code: NCT06075953

Phase 2, Recruiting
Active & Responsive

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

for
Prostate Carcinoma
Location: Seattle WA, Portland OR, San Francisco CA, Duarte CA,
Sponsor: University of Washington

Sex: Male

Age: 40+

Code: NCT04472338

Recruiting